Fundación Canaria de Investigación Sanitaria
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.funcanis.org
Clinical Trials
4
Active:0
Completed:1
Trial Phases
3 Phases
Phase 2:1
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 2
1 (33.3%)Phase 4
1 (33.3%)3D Decision Support Tool for Brain Tumour Surgery Development and Validation: Observational Study
Not yet recruiting
- Conditions
- Brain (Nervous System) CancersBrain Tumor, Primary
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Fundación Canaria de Investigación Sanitaria
- Target Recruit Count
- 320
- Registration Number
- NCT07036783
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)
Phase 4
Recruiting
- Conditions
- Kidney Transplant Failure and Rejection
- Interventions
- Drug: Normal Treatment
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- Fundación Canaria de Investigación Sanitaria
- Target Recruit Count
- 80
- Registration Number
- NCT04936282
- Locations
- 🇪🇸
Hospital Universitario de Canarias, Tenerife, None Selected, Spain
🇪🇸Fundación Puigvert, Barcelona, Spain
🇪🇸Hospital Universitari Valld´Hebron, Barcelona, Spain
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Fundación Canaria de Investigación Sanitaria
- Target Recruit Count
- 70
- Registration Number
- NCT03196388
- Locations
- 🇪🇸
Hospital Ramón y Cajal, Madrid, Spain
News
No news found